Related Experiment Videos
Targeting metalloenzymes: a strategy that works
Richard J White1, Peter S Margolis, Joaquim Trias
1Vicuron Pharmaceuticals, 34790 Ardentech Court, Fremont, CA 94555, USA.
Current Opinion in Pharmacology
|October 16, 2003
Summary
Targeting bacterial metalloenzymes offers a promising strategy for antibacterial drug discovery. This approach leverages genomics and medicinal chemistry to identify and develop novel inhibitors against essential bacterial enzymes.
Area of Science:
- Bacterial genomics
- Medicinal chemistry
- Drug discovery
Background:
- Bacterial genomics has revealed numerous potential antibacterial drug targets.
- Selecting effective targets is crucial for successful antibacterial drug discovery.
- Bacterial metalloenzymes represent a viable class of targets.
Purpose of the Study:
- To highlight the strategic advantage of targeting bacterial metalloenzymes.
- To outline a methodology for identifying and inhibiting metalloenzymes.
- To demonstrate the successful application of this approach in discovering new antibacterial agents.
Main Methods:
- Identifying metalloenzymes via specific motif searches in bacterial genomes.
- Designing inhibitor libraries using advanced medicinal chemistry techniques.
- Optimizing identified lead compounds for enhanced efficacy.
Main Results:
- Successful discovery of in vivo active antibacterial agents.
- Identified inhibitors target essential bacterial enzymes like peptide deformylase and UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase.
- Demonstrated the feasibility of targeting other bacterial metalloenzymes.
Conclusions:
- Targeting bacterial metalloenzymes is a successful strategy for antibacterial drug discovery.
- The described approach enhances the probability of finding effective antibacterial agents.
- Further exploration of bacterial metalloenzymes as drug targets is warranted.